DNASE1L3 and cancer: Furthermore, many human cancers exhibit down-regulation of DNASE1L3 expression, and DNASE1L3 deficiency in mice led to delayed tissue recovery, increased chronic inflammation, immune cell dysfunction, impaired antitumor immunity, and ultimately affected the antitumor immune responses (Li et al. 2023; Liu et al. 2021).